Afatinib CAS 439081-18-2 Purity>99.5% (HPLC) Factory

Apejuwe kukuru:

Orukọ Kemikali: Afatirib

Synonyms: BIBW2992

CAS: 439081-18-2

Mimọ:> 99.5% (HPLC)

Irisi: Pa-White Powder

E-Mail: alvin@ruifuchem.com


Alaye ọja

Jẹmọ Products

ọja Tags

Apejuwe:

Kemikali Properties:

Orukọ Kemikali Afatinib
Awọn itumọ ọrọ sisọ BIBW2992;BIBW-2992;BIBW2992 Ipilẹ Ọfẹ;Tomtovok;(S, E) - N- (4- (3-Chloro-4-Fluorophenylamino) -7- (Tetrahydrofuran-3-yloxy) quinazolin-6-yl) -4- (Dimethylamino) ṣugbọn-2-Enamide
Nọmba CAS 439081-18-2
NỌMBA CAT RF-PI2033
Iṣura Ipo Ninu Iṣura, Iwọn iṣelọpọ Ti o to Awọn Toonu
Fọọmu Molecular C24H25ClFN5O3
Òṣuwọn Molikula 485.94
Solubility Tiotuka ni DMSO
iwuwo 1.380
Brand Ruifu Kemikali

Awọn pato:

Nkan Awọn pato
Ifarahan Pa-White Powder
Idanimọ HPLC, NMR
Mimọ / Analysis Ọna > 99.5% (HPLC)
Ojuami Iyo 100.0 ~ 102.0 ℃
Pipadanu lori Gbigbe <0.50%
Aloku lori Iginisonu <0.20%
Lapapọ Awọn Aimọ <0.50%
Awọn irin Heavy ≤20ppm
NMR julọ.Oniranran Ni ibamu si Eto
Igbeyewo Standard Standard Enterprise
Igbesi aye selifu Awọn oṣu 24 ti o ba fipamọ daradara
Lilo API;Afatinib;Afatinib Dimaleate;NSCLC

Package & Ibi ipamọ:

Package: Igo, apo bankanje aluminiomu, 25kg / Paali ilu, tabi gẹgẹ bi ibeere alabara

Ipò Ìpamọ́:Fipamọ sinu awọn apoti ti a fi edidi ni itura ati ibi gbigbẹ;Dabobo lati ina ati ọrinrin

Awọn anfani:

1

FAQ:

Ohun elo:

Afatinib, ti a tun mọ ni BIW-2992, (CAS: 439081-18-2) jẹ agbara-iran keji ti o ni agbara ati inhibitor meji ti a ko le yipada ti olugba idagba idagbasoke ti epidermal (EGFR) ati awọn olugba idagba idagba eniyan epidermal 2 (HER2) tyrosine kinase, ni idagbasoke nipasẹ Boehringer Ingelheim, Jẹmánì.O lagbara lati ṣe idiwọ iṣẹ-ṣiṣe ti tyrosine kinase ni aiṣe-padabọ nipasẹ ṣiṣe iṣesi Michael pẹlu ẹgbẹ thiol ti cysteine ​​ni ipo 797 ti EGFR.Ni Oṣu Keje Ọjọ 12, Ọdun 2013, o di oogun tuntun fun akàn ẹdọfóró sẹẹli kekere ti a fọwọsi nipasẹ FDA AMẸRIKA labẹ orukọ iṣowo Gilotrif.Oogun yii jẹ tabulẹti kan.O ti wa ni lilo fun awọn itọju ti awọn alaisan ayẹwo pẹlu metastatic ti kii-kekere cell ẹdọfóró akàn (NSCLC) pẹlu awọn isonu ti 19th exon tabi L858R iyipada ni 21th exon ti tumo epidermal idagbasoke ifosiwewe receptor (EGFR) timo nipa lilo ohun elo ti a fọwọsi. nipasẹ FDA.Oogun naa tun munadoko ninu itọju awọn alaisan HER2-rere pẹlu akàn igbaya to ti ni ilọsiwaju.Afatinib jẹ ti kilasi awọn oogun ti a mọ si awọn inhibitors tyrosine kinase.Awọn inhibitors Tyrosine kinase jẹ apẹrẹ lati dènà iṣẹ ti enzymu kan pato ti a pe ni tyrosine kinase.Enzymu yii ṣe ipa nla ninu iṣẹ ti awọn sẹẹli, ati pe o nṣiṣe lọwọ ni igbega idagbasoke idagbasoke ati ilọsiwaju.Afatinib n ṣiṣẹ lati ṣe idiwọ iṣẹ ti awọn iru meji ti awọn kinases tyrosine: olugba idagba ifosiwewe ti epidermal (EGFR) ati Her2, eyiti o jẹ “ifihan ju” nipasẹ ọpọlọpọ awọn oriṣi ti akàn.Nipa didi iṣẹ ti awọn kinases tyrosine wọnyi, Afatinib le ṣe idiwọ awọn sẹẹli alakan lati pin ati dagba.

Kọ ifiranṣẹ rẹ nibi ki o si fi si wa